MiNK Therapeutics, Inc. (INKT)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch INKT
See up to 3 months of INKT. The 7-day demo opens the 1M and 3M ranges and puts INKT on your watchlist.
Start 7-day demoLatest INKT insider trades
About MiNK Therapeutics, Inc. (INKT)
MiNK Therapeutics, Inc. files with the SEC under CIK 0001840229 and is classified as biological products (no diagnostic substances). It is grouped with Health Care companies on this site.
INKT Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 5 | 7,252 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
INKT insider transactions (Form 4)
4142 Form 4 filings on record, the earliest from Dec 3, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Ulf Wiinberg - Director | Grant or award | Common Stock | 1,279 | $10.95 footnote F1 | $14K | |
| ||||||
| John Bradley Holcomb - Director | Grant or award | Common Stock | 1,233 | $10.95 footnote F1 | $14K | |
| ||||||
| Peter Behner - Director | Grant or award | Common Stock | 1,485 | $10.95 footnote F1 | $16K | |
| ||||||
| Barbara Ryan - Director | Grant or award | Common Stock | 1,622 | $10.95 footnote F1 | $18K | |
| ||||||
| Brian Corvese - Director | Grant or award | Common Stock | 1,633 | $10.95 footnote F1 | $18K | |
| ||||||
| Barbara Ryan | Open-market sale | Common Stock | 500 | $12.68 | $6K | |
| Barbara Ryan | Open-market sale | Common Stock | 1,000 | $12.80 | $13K | |
| John Bradley Holcomb | Grant or award | Common Stock | 1,239 | $10.90 footnote F2 | $14K | |
| John Bradley Holcomb | Grant or award | Common Stock | 1,091 | $12.38 footnote F1 | $14K | |
| ||||||
| Barbara Ryan | Grant or award | Common Stock | 1,629 | $10.90 footnote F2 | $18K | |
| Barbara Ryan | Grant or award | Common Stock | 1,434 | $12.38 footnote F1 | $18K | |
| ||||||
| Brian Corvese | Grant or award | Common Stock | 1,640 | $10.90 footnote F2 | $18K | |
| Brian Corvese | Grant or award | Common Stock | 1,444 | $12.38 footnote F1 | $18K | |
| ||||||
| Peter Behner | Grant or award | Common Stock | 1,491 | $10.90 footnote F2 | $16K | |
| Peter Behner | Grant or award | Common Stock | 1,313 | $12.38 footnote F1 | $16K | |
| ||||||
| Ulf Wiinberg | Grant or award | Common Stock | 1,285 | $10.90 footnote F3 | $14K | |
| Ulf Wiinberg | Grant or award | Common Stock | 1,131 | $12.38 footnote F1 | $14K | |
| ||||||
| Barbara Ryan | Open-market sale | Common Stock | 500 | $15.30 | $8K | |
| Barbara Ryan | Open-market sale | Common Stock | 200 | $10.17 | $2K | |
| Barbara Ryan | Open-market sale | Common Stock | 300 | $15.28 | $5K | |
| Barbara Ryan | Open-market sale | Common Stock | 500 | $15.57 | $8K | |
| Barbara Ryan | Open-market sale | Common Stock | 400 | $10.86 | $4K | |
| Barbara Ryan | Open-market sale | Common Stock | 100 | $10.83 | $1K | |
 Jennifer Buell - Officer | Tax withholding / forfeiture | Common Stock | 10,024 | $11.12 | $111K | |
| Jennifer Buell - Officer | Grant or award | Common Stock | 31,474 | $11.12 | $350K | |
| Jennifer Buell - Officer | Grant or award | Stock Option (Right to Buy) | 50,000 | $0.00 | - | |
| Ulf Wiinberg | Grant or award | Stock Option (Right to Buy) | 5,395 | $0.00 | - | |
| Barbara Ryan | Grant or award | Stock Option (Right to Buy) | 5,395 | $0.00 | - | |
| Brian Corvese | Grant or award | Stock Option (Right to Buy) | 5,395 | $0.00 | - | |
| Peter Behner | Grant or award | Stock Option (Right to Buy) | 5,395 | $0.00 | - | |
| Peter Behner | Grant or award | Common Stock | 1,466 | $11.09 footnote F1 | $16K | |
| ||||||
| John Bradley Holcomb | Grant or award | Common Stock | 1,128 | $11.09 footnote F1 | $13K | |
| ||||||
| Robert Peter Kadlec | Grant or award | Common Stock | 1,218 | $11.09 footnote F1 | $14K | |
| ||||||
| Barbara Ryan | Grant or award | Common Stock | 1,601 | $11.09 footnote F1 | $18K | |
| ||||||
| Brian Corvese | Grant or award | Common Stock | 1,612 | $11.09 footnote F1 | $18K | |
| ||||||
| Ulf Wiinberg | Grant or award | Common Stock | 1,263 | $11.09 footnote F1 | $14K | |
| ||||||
| Robert Peter Kadlec | Grant or award | Stock Option (Right to Buy) | 3,225 | $0.00 | - | |
| Peter Behner | Grant or award | Stock Option (Right to Buy) | 3,225 | $0.00 | - | |
| Barbara Ryan | Grant or award | Stock Option (Right to Buy) | 3,225 | $0.00 | - | |
| Brian Corvese | Grant or award | Stock Option (Right to Buy) | 3,225 | $0.00 | - | |
| Ulf Wiinberg | Grant or award | Stock Option (Right to Buy) | 3,225 | $0.00 | - | |
Item 2.02
Item 5.07
Item 2.02, 9.01
Item 2.02, 9.01
Recent INKT Form 144 notices of proposed sale
1An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Buell Jennifer | Officer, PRESIDENT AND CHIEF EXECUTIVE OFFICER | 6,938 | $73K | View on EDGAR |
INKT insider trading FAQ
What is the latest insider trade for INKT?
MiNK Therapeutics, Inc. (INKT) had 5 insider filings in the last 90 days, with the most recent on 2026-09-02. The full record for INKT runs to 42 Form 4 filings, the earliest from 2024-12-03. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying INKT stock?
No insider purchases of INKT were filed in the last 90 days.
How many insiders are selling INKT stock?
No insider sales of INKT were filed in the last 90 days. 8 sales are on record for this company.
Where can I see INKT SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects INKT Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Ulf Wiinberg view on EDGAR
- - John Bradley Holcomb view on EDGAR
- - Peter Behner view on EDGAR
- - Barbara Ryan view on EDGAR
- - Brian Corvese view on EDGAR
- - Barbara Ryan view on EDGAR
- - John Bradley Holcomb view on EDGAR
- - Barbara Ryan view on EDGAR
- - Brian Corvese view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where INKT's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow INKT with a 7-day demo
- INKT on your watchlist
- Every INKT Form 4 filing on record
- Up to 3 months of INKT price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
